Genprex Company Insiders
GNPX Stock | USD 1.10 0.01 0.92% |
Genprex's insiders are aggressively buying. The analysis of the overall insider sentiment regarding Genprex suggests that vertually all insiders are extremely bullish. Genprex employs about 21 people. The company is managed by 12 executives with a total tenure of roughly 49 years, averaging almost 4.0 years of service per executive, having 1.75 employees per reported executive.
Genprex's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
2023-04-21 | John Rodney Varner | Acquired 475 @ 42 | View |
Monitoring Genprex's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Genprex |
Genprex Management Team Effectiveness
The company has return on total asset (ROA) of (1.4594) % which means that it has lost $1.4594 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.1888) %, meaning that it created substantial loss on money invested by shareholders. Genprex's management efficiency ratios could be used to measure how well Genprex manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -3.27 in 2024. Return On Capital Employed is likely to drop to -4.4 in 2024. At this time, Genprex's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 49.1 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 1.7 M in 2024.Common Stock Shares Outstanding is likely to drop to about 1.3 M in 2024. Net Loss is likely to rise to about (16.8 M) in 2024
Genprex Workforce Comparison
Genprex is rated # 3 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 166. Genprex retains roughly 21.0 in number of employees claiming about 13% of equities under Health Care industry.
Genprex Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Genprex insiders, such as employees or executives, is commonly permitted as long as it does not rely on Genprex's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Genprex insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Pearson Robert W. over three months ago Disposition of 161396 shares by Pearson Robert W. of Genprex at 0.96 subject to Rule 16b-3 | ||
Genprex, Inc. over three months ago Acquisition by Genprex, Inc. of 551284 shares of Genprex at 2.15 subject to Rule 16b-3 | ||
John Varner over six months ago Payment of 2642 shares by John Varner of Genprex subject to Rule 16b-3 | ||
Ryan Confer over six months ago Disposition of 1126 shares by Ryan Confer of Genprex at 4.4 subject to Rule 16b-3 | ||
John Varner over a year ago Genprex exotic insider transaction detected | ||
Longnecker Brent M over a year ago Acquisition by Longnecker Brent M of 123795 shares of Genprex subject to Rule 16b-3 | ||
Vaczy Catherine M over a year ago Purchase by Vaczy Catherine M of 20000 shares of Genprex | ||
Ryan Confer over a year ago Acquisition by Ryan Confer of 245000 shares of Genprex subject to Rule 16b-3 |
Genprex Notable Stakeholders
A Genprex stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Genprex often face trade-offs trying to please all of them. Genprex's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Genprex's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ryan MS | CEO, President | Profile | |
MD FACS | Chairman Board | Profile | |
Catherine Esq | General VP | Profile | |
CMA CPA | Co Controller | Profile | |
Kalyn Dabbs | Sr Marketing | Profile | |
Suzanne ThorntonJones | Senior Quality | Profile | |
David Schloss | Senior Resources | Profile | |
William Gannon | Member Affairs | Profile | |
Mark MD | Chief Officer | Profile | |
Thomas Esq | Senior Licensing | Profile | |
CPM EMBA | Chief Officer | Profile | |
John Varner | Chairman, CoFounder | Profile |
About Genprex Management Performance
The success or failure of an entity such as Genprex often depends on how effective the management is. Genprex management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Genprex management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Genprex management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (3.12) | (3.27) | |
Return On Capital Employed | (4.19) | (4.40) | |
Return On Assets | (2.89) | (3.04) | |
Return On Equity | (4.16) | (4.37) |
Please note, the imprecision that can be found in Genprex's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genprex. Check Genprex's Beneish M Score to see the likelihood of Genprex's management manipulating its earnings.
Genprex Workforce Analysis
Traditionally, organizations such as Genprex use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Genprex within its industry.Genprex Manpower Efficiency
Return on Genprex Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.5M | |
Net Loss Per Executive | 2.6M | |
Working Capital Per Employee | 203.7K | |
Working Capital Per Executive | 356.5K |
Additional Tools for Genprex Stock Analysis
When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.